Föreläsningar och seminarier MTC, CMM, CID seminarium: "Cell wall biosynthesis as a target for (novel) antibiotics"

2019-10-03 14:00 - 15:00 Add to iCal
Karolinska Universitetssjukhuset, Solna CMM, L8:00, Solna

Välkommen till ett seminarium med Tanja Schneider, Institute for Pharmaceutical Microbiology, University of Bonn, Germany.


"Cell Wall Biosynthesis as a Target for (Novel) Antibiotics"


Tanja Schneider, Institute for Pharmaceutical Microbiology, University of Bonn, Germany

Tanja Schneider is a leading scientist in the field of antibiotic development and characterization. She was part of the study that identified the ’new’ antibiotic teixobactin and her lab is focused on identification and characterization of novel cell wall targeting compounds.

A new antibiotic kills pathogens without detectable resistance.
Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP, et al
Nature 2015 Jan;517(7535):455-9

Coordination of capsule assembly and cell wall biosynthesis in Staphylococcus aureus.
Rausch M, Deisinger JP, Ulm H, Müller A, Li W, Hardt P, et al
Nat Commun 2019 03;10(1):1404

The cell wall precursor lipid II acts as a molecular signal for the Ser/Thr kinase PknB of Staphylococcus aureus.
Hardt P, Engels I, Rausch M, Gajdiss M, Ulm H, Sass P, et al
Int. J. Med. Microbiol. 2017 Jan;307(1):1-10

Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.
Schneider T, Kruse T, Wimmer R, Wiedemann I, Sass V, Pag U, et al
Science 2010 May;328(5982):1168-72


Peter Mellroth